Precision Medicine in Oncology
The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move t...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2019 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (163 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548697104498 |
---|---|
ctrlnum |
(CKB)4920000000094081 (oapen)https://directory.doabooks.org/handle/20.500.12854/56871 (EXLCZ)994920000000094081 |
collection |
bib_alma |
record_format |
marc |
spelling |
Andrea Lunardi auth Precision Medicine in Oncology Frontiers Media SA 2019 1 electronic resource (163 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move towards this innovative approach: i) unprecedented improvements in disease modeling in silico, in vitro and in vivo; ii) acquisition of a wide range of biomedical information combined with the development of computational toolsets for flexible and integrative analyses of multi-assay datasets. Our deeper understanding of oncogenic mechanisms has finally begun to have a crucial impact on clinical decisions at several steps, from cancer prevention and diagnosis to therapeutic intervention. However, precision oncology still encounters several unresolved hurdles including tumour heterogeneity and recurrence as well as unexplained drug resistance and lack of effective ways to monitor response to therapeutic treatments. Notably, limitations in biomedical research regulation and governance represent additional debatable issues that need careful consideration. English computational biology synthetic biology pathology noncoding RNA aberration precision medicine in vivo preclinical platform oncology 2-88945-705-2 Angela Re auth Caterina Nardella auth Alessandro Quattrone auth |
language |
English |
format |
eBook |
author |
Andrea Lunardi |
spellingShingle |
Andrea Lunardi Precision Medicine in Oncology Frontiers Research Topics |
author_facet |
Andrea Lunardi Angela Re Caterina Nardella Alessandro Quattrone |
author_variant |
a l al |
author2 |
Angela Re Caterina Nardella Alessandro Quattrone |
author2_variant |
a r ar c n cn a q aq |
author_sort |
Andrea Lunardi |
title |
Precision Medicine in Oncology |
title_full |
Precision Medicine in Oncology |
title_fullStr |
Precision Medicine in Oncology |
title_full_unstemmed |
Precision Medicine in Oncology |
title_auth |
Precision Medicine in Oncology |
title_new |
Precision Medicine in Oncology |
title_sort |
precision medicine in oncology |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2019 |
physical |
1 electronic resource (163 p.) |
isbn |
2-88945-705-2 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT andrealunardi precisionmedicineinoncology AT angelare precisionmedicineinoncology AT caterinanardella precisionmedicineinoncology AT alessandroquattrone precisionmedicineinoncology |
status_str |
n |
ids_txt_mv |
(CKB)4920000000094081 (oapen)https://directory.doabooks.org/handle/20.500.12854/56871 (EXLCZ)994920000000094081 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Precision Medicine in Oncology |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1787551938732097536 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02302nam-a2200397z--4500</leader><controlfield tag="001">993548697104498</controlfield><controlfield tag="005">20231214133315.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094081</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/56871</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094081</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Andrea Lunardi</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Precision Medicine in Oncology</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (163 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move towards this innovative approach: i) unprecedented improvements in disease modeling in silico, in vitro and in vivo; ii) acquisition of a wide range of biomedical information combined with the development of computational toolsets for flexible and integrative analyses of multi-assay datasets. Our deeper understanding of oncogenic mechanisms has finally begun to have a crucial impact on clinical decisions at several steps, from cancer prevention and diagnosis to therapeutic intervention. However, precision oncology still encounters several unresolved hurdles including tumour heterogeneity and recurrence as well as unexplained drug resistance and lack of effective ways to monitor response to therapeutic treatments. Notably, limitations in biomedical research regulation and governance represent additional debatable issues that need careful consideration.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">computational biology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">synthetic biology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">noncoding RNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aberration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vivo preclinical platform</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oncology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-705-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Angela Re</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Caterina Nardella</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alessandro Quattrone</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:49:56 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338851680004498&Force_direct=true</subfield><subfield code="Z">5338851680004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338851680004498</subfield></datafield></record></collection> |